Author
Bhairavi Tolani
Also Known As
B Tolani, Bhairavi (Vivi) Tolani, Bhairavi Tolani, Tolani B, Tolani, Bhairavi (Vivi) (author)
22
Publications
1K
Citations
14
H-Index
7
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 2 | 2 | 212 |
2 | Immunology | 2 | 2 | 212 |
3 | Pathology | 2 | 2 | 212 |
4 | Immunotherapy | 2 | 2 | 212 |
5 | Tumor Biology | 1 | 1 | 98 |
Bhairavi Tolani
×
11
Publications
409
Citations
11
H-Index
| Year | Citations | |
|---|---|---|
Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors Hittu Matta, Bhairavi Tolani, Timothy J. Triche, Hematological MalignancyLymphoid NeoplasiaPrimary Effusion LymphomaIkzf1-irf4-myc AxisMedicine | 2015 | 114 |
2013 | 98 | |
2022 | 34 | |
2017 | 26 | |
2012 | 25 | |
2012 | 25 | |
2014 | 24 | |
2016 | 20 | |
2015 | 20 | |
2018 | 12 |
Page 1
Page 1